Abstract: The present invention relates to glycosylation of immunoglobulin single variable domains (ISVDs). The present invention particularly relates to specific positions within the amino acid sequence of an ISVD for use as glycosylation acceptor sites. The present invention also relates to ISVDs modified with specific glycans at the specified glycosylation acceptor sites and to conjugates thereof. The present invention also relates to polypeptides comprising at least one ISVD of the present technology, at least one ISVD with specific glycans or at least one conjugate thereof. The invention furthermore relates to a nucleotide sequence or nucleic acid encoding such ISVD and/or polypeptide, a method of making such ISVDs and/or polypeptides, a composition comprising such ISVDs, conjugates and/or polypeptides, and the use of the polypeptide, nucleic sequence or nucleic acid, conjugate or composition according to the present technology in a medicament.
| # | Name | Date |
|---|---|---|
| 1 | 202517121890-TRANSLATIOIN OF PRIOIRTY DOCUMENTS ETC. [04-12-2025(online)].pdf | 2025-12-04 |
| 2 | 202517121890-STATEMENT OF UNDERTAKING (FORM 3) [04-12-2025(online)].pdf | 2025-12-04 |
| 4 | 202517121890-Sequence Listing in PDF [04-12-2025(online)].pdf | 2025-12-04 |
| 5 | 202517121890-REQUEST FOR EXAMINATION (FORM-18) [04-12-2025(online)].pdf | 2025-12-04 |
| 6 | 202517121890-FORM 18 [04-12-2025(online)].pdf | 2025-12-04 |
| 7 | 202517121890-FORM 1 [04-12-2025(online)].pdf | 2025-12-04 |
| 8 | 202517121890-DRAWINGS [04-12-2025(online)].pdf | 2025-12-04 |
| 9 | 202517121890-DECLARATION OF INVENTORSHIP (FORM 5) [04-12-2025(online)].pdf | 2025-12-04 |
| 10 | 202517121890-COMPLETE SPECIFICATION [04-12-2025(online)].pdf | 2025-12-04 |